Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 β production in a cancer-induced pain model in mice.
about
Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 β production in a cancer-induced pain model in mice.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Z-360, a novel therapeutic age ...... er-induced pain model in mice.
@en
Z-360, a novel therapeutic age ...... er-induced pain model in mice.
@nl
type
label
Z-360, a novel therapeutic age ...... er-induced pain model in mice.
@en
Z-360, a novel therapeutic age ...... er-induced pain model in mice.
@nl
prefLabel
Z-360, a novel therapeutic age ...... er-induced pain model in mice.
@en
Z-360, a novel therapeutic age ...... er-induced pain model in mice.
@nl
P2093
P2860
P356
P1433
P1476
Z-360, a novel therapeutic age ...... er-induced pain model in mice.
@en
P2093
Hiroki Hamano
Hiroki Kato
Koichi Seto
Koji Yoshinaga
Mineo Takei
Nobuyoshi Kobayashi
Yuki Orikawa
P2860
P2888
P356
10.1186/1744-8069-6-72
P577
2010-10-28T00:00:00Z
P5875
P6179
1017048050